245 related articles for article (PubMed ID: 18386884)
61. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
[TBL] [Abstract][Full Text] [Related]
62. Synthesis and biological evaluation of 1,4-diaryl-2-azetidinones as specific anticancer agents: activation of adenosine monophosphate activated protein kinase and induction of apoptosis.
Tripodi F; Pagliarin R; Fumagalli G; Bigi A; Fusi P; Orsini F; Frattini M; Coccetti P
J Med Chem; 2012 Mar; 55(5):2112-24. PubMed ID: 22329561
[TBL] [Abstract][Full Text] [Related]
63. Synthesis and antitumor activity of benzils related to combretastatin A-4.
Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M
Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509
[TBL] [Abstract][Full Text] [Related]
64. Discovery of substituted 4-anilino-2-(2-pyridyl)pyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. Part 1: structure-activity relationships of the 4-anilino group.
Sirisoma N; Kasibhatla S; Nguyen B; Pervin A; Wang Y; Claassen G; Tseng B; Drewe J; Cai SX
Bioorg Med Chem; 2006 Dec; 14(23):7761-73. PubMed ID: 16919962
[TBL] [Abstract][Full Text] [Related]
65. [(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G(2)/M phase and apoptosis.
Pojarová M; Kaufmann D; Gastpar R; Nishino T; Reszka P; Bednarski PJ; von Angerer E
Bioorg Med Chem; 2007 Dec; 15(23):7368-79. PubMed ID: 17889547
[TBL] [Abstract][Full Text] [Related]
66. Benzoylphenylurea sulfur analogues with potent antitumor activity.
Hallur G; Jimeno A; Dalrymple S; Zhu T; Jung MK; Hidalgo M; Isaacs JT; Sukumar S; Hamel E; Khan SR
J Med Chem; 2006 Apr; 49(7):2357-60. PubMed ID: 16570932
[TBL] [Abstract][Full Text] [Related]
67. The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.
Zhang LH; Wu L; Raymon HK; Chen RS; Corral L; Shirley MA; Narla RK; Gamez J; Muller GW; Stirling DI; Bartlett JB; Schafer PH; Payvandi F
Cancer Res; 2006 Jan; 66(2):951-9. PubMed ID: 16424030
[TBL] [Abstract][Full Text] [Related]
68. 2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors.
Chuang HY; Chang JY; Lai MJ; Kuo CC; Lee HY; Hsieh HP; Chen YJ; Chen LT; Pan WY; Liou JP
ChemMedChem; 2011 Mar; 6(3):450-6. PubMed ID: 21360819
[TBL] [Abstract][Full Text] [Related]
69. Novel benzopyridothiadiazepines as potential active antitumor agents.
Lebegue N; Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Chavatte P; Berthelot P
J Med Chem; 2005 Nov; 48(23):7363-73. PubMed ID: 16279796
[TBL] [Abstract][Full Text] [Related]
70. Novel diarylsulfonylurea derivatives as potent antimitotic agents.
Kim S; Park JH; Koo SY; Kim JI; Kim MH; Kim JE; Jo K; Choi HG; Lee SB; Jung SH
Bioorg Med Chem Lett; 2004 Dec; 14(24):6075-8. PubMed ID: 15546733
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors.
Ouyang X; Chen X; Piatnitski EL; Kiselyov AS; He HY; Mao Y; Pattaropong V; Yu Y; Kim KH; Kincaid J; Smith L; Wong WC; Lee SP; Milligan DL; Malikzay A; Fleming J; Gerlak J; Deevi D; Doody JF; Chiang HH; Patel SN; Wang Y; Rolser RL; Kussie P; Labelle M; Tuma MC
Bioorg Med Chem Lett; 2005 Dec; 15(23):5154-9. PubMed ID: 16198562
[TBL] [Abstract][Full Text] [Related]
72. Synthesis, biological evaluation, and molecular docking studies of 2,6-dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime derivatives as novel antitubulin agents.
Zhao TT; Lu X; Yang XH; Wang LM; Li X; Wang ZC; Gong HB; Zhu HL
Bioorg Med Chem; 2012 May; 20(10):3233-41. PubMed ID: 22512906
[TBL] [Abstract][Full Text] [Related]
73. Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studies.
Burja B; Cimbora-Zovko T; Tomić S; Jelusić T; Kocevar M; Polanc S; Osmak M
Bioorg Med Chem; 2010 Apr; 18(7):2375-87. PubMed ID: 20338766
[TBL] [Abstract][Full Text] [Related]
74. Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerization inhibitors.
Nakamura H; Kuroda H; Saito H; Suzuki R; Yamori T; Maruyama K; Haga T
ChemMedChem; 2006 Jul; 1(7):729-40. PubMed ID: 16902927
[TBL] [Abstract][Full Text] [Related]
75. Benzopyridooxathiazepine derivatives as novel potent antimitotic agents.
Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Berthelot P; Lebegue N
Bioorg Med Chem; 2009 Feb; 17(3):1132-8. PubMed ID: 19162484
[TBL] [Abstract][Full Text] [Related]
76. 2-Anilino-3-Aroylquinolines as Potent Tubulin Polymerization Inhibitors.
Srikanth PS; Nayak VL; Suresh Babu K; Kumar GB; Ravikumar A; Kamal A
ChemMedChem; 2016 Sep; 11(18):2050-62. PubMed ID: 27465681
[TBL] [Abstract][Full Text] [Related]
77. Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers.
Kamal A; Kumar GB; Vishnuvardhan MV; Shaik AB; Reddy VS; Mahesh R; Sayeeda IB; Kapure JS
Org Biomol Chem; 2015 Apr; 13(13):3963-81. PubMed ID: 25721862
[TBL] [Abstract][Full Text] [Related]
78. Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents.
Gurjar MK; Wakharkar RD; Singh AT; Jaggi M; Borate HB; Shinde PD; Verma R; Rajendran P; Dutt S; Singh G; Sanna VK; Singh MK; Srivastava SK; Mahajan VA; Jadhav VH; Dutta K; Krishnan K; Chaudhary A; Agarwal SK; Mukherjee R; Burman AC
J Med Chem; 2007 Apr; 50(8):1744-53. PubMed ID: 17373779
[TBL] [Abstract][Full Text] [Related]
79. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide.
Iguchi T; Yachide-Noguchi T; Hashimoto Y; Nakazato S; Sagawa M; Ikeda Y; Kizaki M
Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782
[TBL] [Abstract][Full Text] [Related]
80. Discovery and Optimization of Novel 5-Indolyl-7-arylimidazo[1,2-a]pyridine-8-carbonitrile Derivatives as Potent Antitubulin Agents Targeting Colchicine-binding Site.
Zhai X; Wang X; Wang J; Liu J; Zuo D; Jiang N; Zeng T; Yang X; Jing T; Gong P
Sci Rep; 2017 Feb; 7():43398. PubMed ID: 28240326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
